Goldstein DB, Cavalleri GL: Genomics: Understanding human diversity. Nature. 2005, 437: 1241-1242. 10.1038/4371241a.
Article
CAS
PubMed
Google Scholar
A haplotype map of the human genome. Nature. 2005, International HapMap Consortium, 437: 1299-1320. 10.1038/nature04226.
Brookes AJ: The essence of SNPs. Gene. 1999, 234: 177-186. 10.1016/S0378-1119(99)00219-X.
Article
CAS
PubMed
Google Scholar
Hoehe MR, Timmermann B, Lehrach H: Human inter-individual DNA sequence variation in candidate genes, drug targets, the importance of haplotypes and pharmacogenomics. Curr Pharm Biotechnol. 2003, 4: 351-378. 10.2174/1389201033377300.
Article
CAS
PubMed
Google Scholar
Maitland ML, DiRienzo A, Ratain MJ: Interpreting disparate responses to cancer therapy: The role of human population genetics. J Clin Oncol. 2006, 24: 2151-2157. 10.1200/JCO.2005.05.2282.
Article
PubMed
Google Scholar
Masood E: As consortium plans free SNP map of human genome. Nature. 1999, 398: 545-546.
Article
CAS
PubMed
Google Scholar
Vitkup D, Sander C, Church GM: The amino-acid mutational spectrum of human genetic disease. Genome Biol. 2003, 4: R72-10.1186/gb-2003-4-11-r72.
Article
PubMed Central
PubMed
Google Scholar
Wang Z, Moult J: SNPs, protein structure, and disease. Hum Mutat. 2001, 17: 263-270. 10.1002/humu.22.
Article
PubMed
Google Scholar
Zanotti G, Berni R: Plasma retinol-binding protein: structure and interactions with retinol, retinoids, and transthyretin. Vitam Horm. 2004, 69: 271-295.
Article
CAS
PubMed
Google Scholar
Seelinger MW, Biesalski HK, Wissinger B, Gollnick H, et al: Phenotype in retinol deficiency due to a hereditary defect in the retinol binding protein synthesis. Invest Ophthalmol Vis Sci. 1999, 40: 3-11.
Google Scholar
Yao-Borengasser A, Varma V, Bodles AM, Rasouli N, et al: Retinol binding protein 4 expression in humans: Relationship to insulin resistance, inflammation, and response to pioglitazone. J Clin Endocrinol Metab. 2007, 92: 2590-2597. 10.1210/jc.2006-0816.
Article
PubMed Central
CAS
PubMed
Google Scholar
Hash RB: Hereditary hemochromatosis. J Am Board Fam Pract. 2001, 14: 266-273.
CAS
PubMed
Google Scholar
Kim S, Misra A: SNP genotyping: Technologies and bio-medical applications. Annu Rev Biomed Eng. 2007, 9: 289-320. 10.1146/annurev.bioeng.9.060906.152037.
Article
CAS
PubMed
Google Scholar
Delrieu O, Bowman C: Visualizing gene determinants of disease in drug discovery. Pharmacogenomics. 2006, 7: 311-329. 10.2217/14622416.7.3.311.
Article
CAS
PubMed
Google Scholar
Giacomini KM, Brett CM, Altman RB, Benowitz NL, et al: The pharmacogenetics research network: From SNP discovery to clinical drug response. Clin Pharmacol Ther. 2007, 81: 328-345. 10.1038/sj.clpt.6100087.
Article
CAS
PubMed
Google Scholar
McLeod HL, Evans WE: Pharmacogenomics: Unlocking the human genome for better drug therapy. Annu Rev Pharmacol Toxicol. 2001, 41: 101-121. 10.1146/annurev.pharmtox.41.1.101.
Article
CAS
PubMed
Google Scholar
Evans WE, Johnson JA: Pharmacogenomics: The inherited basis for interindividual differences in drug response. Annu Rev Genomics Hum Genet. 2001, 2: 9-39. 10.1146/annurev.genom.2.1.9.
Article
CAS
PubMed
Google Scholar
Shah RR: Mechanistic basis of adverse drug reactions: The perils of inappropriate dose schedules. Expert Opin Drug Saf. 2005, 4: 103-128. 10.1517/14740338.4.1.103.
Article
CAS
PubMed
Google Scholar
Rane A: Postgenomic prospects of success in drug development and pharmacotherapy. Pharmacogenomics J. 2001, 1: 6-9. 10.1038/sj.tpj.6500013.
Article
CAS
PubMed
Google Scholar
Bosch TM, Meijerman I, Beijnen JH, Schellens JH: Genetic polymorphisms of drug-metabolising enzymes and drug transporters in the chemotherapeutic treatment of cancer. Clin Pharmacokinet. 2006, 45: 253-285. 10.2165/00003088-200645030-00003.
Article
CAS
PubMed
Google Scholar
Lai E: Application of SNP technologies in medicine: Lessons learned and future challenges. Genome Res. 2001, 11: 927-929. 10.1101/gr.192301.
Article
CAS
PubMed
Google Scholar
Klein TE, Chang JT, Cho MK, Easton KL, et al: Integrating genotype and phenotype information: An overview of the PharmGKB project. Pharmacogenetics Research Network and Knowledge Base. Pharmacogenomics J. 2001, 1: 167-170. 10.1038/sj.tpj.6500035.
Article
CAS
PubMed
Google Scholar
Ustav M, Stenlund A: Transient replication of BPV-1 requires two viral polypeptides encoded by the E1 and E2 open reading frames. EMBOJ. 1991, 10: 449-457.
CAS
Google Scholar
Gloss B, Bernard HU, Seedorf K, Klock G: The upstream regulatory region of the human papilloma virus-16 contains an E2 protein-independent enhancer which is specific for cervical carcinoma cells and regulated by glucocorticoid hormones. EMBO J. 1987, 6: 3735-3743.
PubMed Central
CAS
PubMed
Google Scholar
Wilson R, Fehrmann F, Laimins LA: Role of the E1-E4 protein in the differentiation-dependent life cycle of human papilloma-virus type 31. J Virol. 2005, 79: 6732-6740. 10.1128/JVI.79.11.6732-6740.2005.
Article
PubMed Central
CAS
PubMed
Google Scholar
Fehrmann F, Klumpp DJ, Laimins LA: Human papillo-mavirus type 31 E5 protein supports cell cycle progression and activates late viral functions upon epithelial differentiation. J Virol. 2003, 77: 2819-2831. 10.1128/JVI.77.5.2819-2831.2003.
Article
PubMed Central
CAS
PubMed
Google Scholar
Zhang B, Li P, Wang E, Brahmi Z, et al: The E5 protein of human papillomavirus type 16 perturbs MHC class II antigen maturation in human foreskin keratinocytes treated with interferon-gamma. Virology. 2003, 310: 100-108. 10.1016/S0042-6822(03)00103-X.
Article
CAS
PubMed
Google Scholar
Snijders PJ, Steenbergen RD, Heideman DA, Meijer CJ: HPV-mediated cervical carcinogenesis: Concepts and clinical implications. J Pathol. 2006, 208: 152-164. 10.1002/path.1866.
Article
CAS
PubMed
Google Scholar
Stanley M: Immunobiology of HPV and HPV vaccines. Gynecol Oncol. 2008, 109: S15-S21. 10.1016/j.ygyno.2008.02.003.
Article
CAS
PubMed
Google Scholar
Chow VT, Leong PW: Complete nucleotide sequence, genomic organization and phylogenetic analysis of a novel genital human papillomavirus type, HLT7474-S. J Gen Virol. 1999, 80: 2923-2929.
Article
CAS
PubMed
Google Scholar
de Villiers EM, Fauquet C, Broker TR, Bernard HU, et al: Classification of papillomaviruses. Virology. 2004, 324: 17-27. 10.1016/j.virol.2004.03.033.
Article
CAS
PubMed
Google Scholar
Delius H, Saegling B, Bergmann K, Shamanin V, et al: The genomes of three of four novel HPV types, defined by differences of their L1 genes, show high conservation of the E7 gene and the URR. Virology. 1998, 240: 359-365. 10.1006/viro.1997.8943.
Article
CAS
PubMed
Google Scholar
Forslund O, Hansson BG: Human papillomavirus type 70 genome cloned from overlapping PCR products: Complete nucleotide sequence and genomic organization. J Clin Microbiol. 1996, 34: 802-809.
PubMed Central
CAS
PubMed
Google Scholar
Ho L, Chan SY, Chow V, Chong T, et al: Sequence variants of human papillomavirus type 16 in clinical samples permit verification and extension of epidemiological studies and construction of a phylogenetic tree. J Clin Microbiol. 1991, 29: 1765-1772.
PubMed Central
CAS
PubMed
Google Scholar
Chan SY, Ho L, Ong CK, Chow V, et al: Molecular variants of human papillomavirus type 16 from four continents suggest ancient pandemic spread of the virus and its coevolution with humankind. J Virol. 1992, 66: 2057-2066.
PubMed Central
CAS
PubMed
Google Scholar
Radivojac P, Iakoucheva LM, Oldfield CJ, Obradovic Z, et al: Intrinsic disorder and functional proteomics. Biophys J. 2007, 92: 1439-1456. 10.1529/biophysj.106.094045.
Article
PubMed Central
CAS
PubMed
Google Scholar
Shimizu K, Hirose S, Noguchi T: POODLE-S: Web application for predicting protein disorder by using physicochemical features and reduced amino acid set of a position-specific scoring matrix. Bioinformatics. 2007, 23: 2337-2338. 10.1093/bioinformatics/btm330.
Article
CAS
PubMed
Google Scholar
Hirose S, Shimizu K, Kanai S, Kuroda Y, Noguchi T: POODLE-L: A two-level SVM prediction system for reliably predicting long disordered regions. Bioinformatics. 2007, 23: 2046-2053. 10.1093/bioinformatics/btm302.
Article
CAS
PubMed
Google Scholar
Uversky VN, Roman A, Oldfield CJ, Dunker AK: Protein intrinsic disorder and human papillomaviruses: Increased amount of disorder in E6 and E7 oncoproteins from high risk HPVs. J Proteome Res. 2006, 5: 1829-1842. 10.1021/pr0602388.
Article
CAS
PubMed
Google Scholar
Ma HC, Chen JM, Chen JW, Sun YX, et al: The panorama of the diversity of H5 subtype influenza viruses. Virus Genes. 2007, 34: 283-287. 10.1007/s11262-006-0018-3.
Article
CAS
PubMed
Google Scholar
Chow VT, Tambyah PA, Goh KT: To kill a mocking bird flu?. Ann Acad Med. 2008, 37: 451-453.
Google Scholar
Wallace RG, Hodac H, Lathrop RH, Fitch WM: A statistical phylogeography of influenza A H5N1. Proc Natl Acad Sci. 2007, USA, 104: 4473-4478. 10.1073/pnas.0700435104.
Google Scholar
Narasaraju T, Sim MK, Ng HH, Phoon MC, et al: Adaptation of human influenza H3N2 virus in a mouse pneumonitis model: Insights into viral virulence, tissue tropism and host pathogenesis's. Microbes Infect. 2009, 11: 2-11. 10.1016/j.micinf.2008.09.013.
Article
CAS
PubMed
Google Scholar
Zhao B, Sakharkar KR, Lim CS, Kangueane P, et al: MHC-peptide binding prediction for epitope based vaccine design. Int J Integr Biol. 2007, 1: 127-140.
CAS
Google Scholar
Sakharkar MK, Sakharkar KR, Pervaiz S: Druggability of human disease genes. Int J Biochem Cell Biol. 2007, 39: 1156-1164. 10.1016/j.biocel.2007.02.018.
Article
CAS
PubMed
Google Scholar